12th UPCA Ratification and other UPC News

Published Februar 2017

12th UPCA Ratification and other UPC News

Italy has become the 12th country to officially ratify the UPC Agreement. The full details on ratification progress can be found here. The UK is expected to ratify next.  News of other ratifications was discussed last week when Estelle Senior from HGF attended the UPP2017 conference on the UP & UPC.

Here are some headlines and latest news from the event:

  • The plan to have the UPC in operation by December 2017 is still very much on the agenda. As Italy have now formally ratified, once the UK and Germany ratify; that means the UP will cover at least 14 member states. It was said at least a further 5 member states are expected to ratify before December (Greece, Hungary, Latvia, Estonia, Romania). There is also an understanding that all member states are “obliged” to ratify the agreement, but no timescale is given for this. The rumour that Germany would not ratify in light of “hard Brexit” was denied by Alexander Ramsay, the chairman of the prep committee.
  • There was a lot of discussion around the issue of a potential UP colliding with an earlier prior national right (including utility models in some states); and that this could result in the entire UP being lost without the option to convert to national rights; the EPO commented that they hope a “top up” search before grant would reduce this risk. Some member states are looking again at whether allowing conversion would be possible in national law; but this was not discussed in any detail and was speculation.
  • The EPO indicated they working on a sunrise period to apply for UPs 3 months prior to UPC start, so possibly from 1 September 2017; provisions to delay grant to allow for unitary protection are also being considered. The EPO are expected to make a formal announcement on this.
  • SPCs – the EPO spoke about the fact that the European Commission envisages the creation of Unitary SPCs; however this is probably unlikely to be achieved in the short term. Pending the creation of a Unitary SPC, the Commission plans to issue a Communication clarifying that national SPCs can be obtained on the basis of a Unitary Patent.
  • The final UPC Rules of Procedure are expected to be adopted in March 2017 – some minor changes (to opt out rules) and incorporation of fees is expected.
  • The technicalities of the opt out were discussed; there must be certification that the person lodging the application is authorised by all “proprietors” etc. and a mandate must be uploaded if this person is not a “representative” registered with the UPC. A representative is not required to lodge a mandate but all users (including representatives) will need identity authentication. And there must also be given a declaration that no action has been commenced which would prevent the opt-out (ie a UPC action) or withdrawal of the opt-out (ie a national court action). If certain details required for opting out (Rule 5.3) are missing or incorrect the opt-out is ineffective until corrected.
  • There was a long session on costs of a UP vs EPs, but at this stage, the conclusion was that cost comparison was almost impossible without knowing what states a UP will ultimately cover, and only renewal fees could be taken into account.
  • On the litigation side, there was some discussion that smaller patentees may prefer UPs, as any potential litigation resulting from a UP would be before one court, rather than before multiple jurisdictions, so there costs may be more predictable. Photos of the UK section of the Central Division were shown, as this is now ready for operation.

Aktuelle Neuigkeiten

Event - 12. November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Veranstaltungsdetails
Event - 15. Dezember 2026

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Veranstaltungsdetails
Event - 28. Oktober 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Veranstaltungsdetails

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Weiterlesen
Event - 28. Oktober 2026

HGF nimmt an der KINPA-Konferenz 2026 teil

HGF freut sich auf die Teilnahme an der KINPA-Konferenz 2026, die am 28. Oktober in Seoul, Südkorea, stattfindet. Als Koreas größte Veranstaltung zum Thema geistiges Eigentum bringt die Konferenz mehr …

Veranstaltungsdetails
Event - 17. bis 19. November 2026

HGF nimmt an der IPBC Asia 2026 teil

HGF freut sich bekannt zu geben, dass Partnerin Dr. Jennifer Uno an der IPBC Asia 2026 teilnehmen wird, die vom 17. bis 19. November 2026 in Tokio, Japan, stattfindet. Als …

Veranstaltungsdetails

HGF im Chambers and Partners UK Guide 2027 ausgezeichnet

HGF freut sich, erneut im Chambers and Partners UK Guide 2027 ausgezeichnet worden zu sein. Sowohl die Kanzlei als auch einzelne Berufsträger haben in mehreren Regionen hervorragende Platzierungen erzielt. Der …

Weiterlesen
Event - 4. November 2026

IAM Navigating the UPC conference

HGF are gold sponsors of the IAM Live Navigating the UPC conference. IAM Live: Navigating the UPC returns to Paris in November bringing together over 180 industry leaders for an …

Veranstaltungsdetails